Wockhardt recalls 109,744 bottles of a high blood pressure drug: Report

Wockhardt has reportedly recalled 109,744 bottles of a high blood pressure drug -- metoprolol succinate -- in the United States after it failed a dissolution test. Metoprolol succinate extended release is a cheaper generic form of AstraZeneca Plc’s branded drug Toprol. Dissolution tests are commonly conducted to check the time taken for the active ingredient in a drug to release into the body, and help predict how the drug performs inside the body. Last year, two of the company’s manufacturing plants were banned from exporting to the United States after the FDA found violations of manufacturing standards that the agency believed could compromise the quality of drugs. One of those plants was making metoprolol succinate for the United States.